A phase II trial of AZD1152 in relapsed/refractory diffuse large B-cell lymphoma

被引：27

作者：

Collins, Graham P. ^{[1
]}

Eyre, Toby A. ^{[1
]}

Linton, Kim M. ^{[2
]}

Radford, John ^{[2
]}

Vallance, Grant D. ^{[1
]}

Soilleux, Elizabeth ^{[3
]}

Hatton, Chris ^{[1
]}

机构：

[1] Churchill Hosp, Oxford Univ Hosp NHS Trust, Dept Haematol, Oxford OX3 7LJ, England

[2] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England

[3] John Radcliffe Hosp, Oxford Univ Hosp NHS Trust, Dept Cellular Pathol, Oxford OX3 9DU, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2015年 / 170卷 / 06期

关键词：

barasertib; AZD1152; Aurora B kinase; diffuse large B-cell lymphoma; lymphoid malignancies; ACUTE MYELOID-LEUKEMIA; BARASERTIB AZD1152; KINASE INHIBITOR; AURORA; EFFICACY; SAFETY; PHARMACOKINETICS;

D O I：

10.1111/bjh.13333

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：886 / 890

页数：5

共 9 条

[1] Clinical evaluation of AZD1152, an i.v. inhibitor of Aurora B kinase, in patients with solid malignant tumors [J].

Boss, D. S. ;

Witteveen, P. O. ;

van der Sar, J. ;

Lolkema, M. P. ;

Voest, E. E. ;

Stockman, P. K. ;

Ataman, O. ;

Wilson, D. ;

Das, S. ;

Schellens, J. H. .

ANNALS OF ONCOLOGY, 2011, 22 (02) :431-437

[2] Revised response criteria for malignant lymphoma [J].

Cheson, Bruce D. ;

Pfistner, Beate ;

Juweid, Malik E. ;

Gascoyne, Randy D. ;

Specht, Lena ;

Horning, Sandra J. ;

Coiffier, Bertrand ;

Fisher, Richard I. ;

Hagenbeek, Anton ;

Zucca, Emanuele ;

Rosen, Steven T. ;

Stroobants, Sigrid ;

Lister, T. Andrew ;

Hoppe, Richard T. ;

Dreyling, Martin ;

Tobinai, Kensei ;

Vose, Julie M. ;

Connors, Joseph M. ;

Federico, Massimo ;

Diehl, Volker .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :579-586

[3] Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas [J].

Friedberg, Jonathan W. ;

Mahadevan, Daruka ;

Cebula, Erin ;

Persky, Daniel ;

Lossos, Izidore ;

Agarwal, Amit B. ;

Jung, JungAh ;

Burack, Richard ;

Zhou, Xiaofei ;

Leonard, E. Jane ;

Fingert, Howard ;

Danaee, Hadi ;

Bernstein, Steven H. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (01) :44-U122

[4] Analysis of Aurora B kinase in non-Hodgkin lymphoma [J].

Ikezoe, Takayuki ;

Takeuchi, Tamotsu ;

Yang, Jing ;

Adachi, Yoshihiro ;

Nishioka, Chie ;

Furihata, Mutsuo ;

Koeffler, H. Phillip ;

Yokoyama, Akihito .

LABORATORY INVESTIGATION, 2009, 89 (12) :1364-1373

[5] Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia [J].

Kantarjian, Hagop M. ;

Martinelli, Giovanni ;

Jabbour, Elias J. ;

Quintas-Cardama, Alfonso ;

Ando, Kiyoshi ;

Bay, Jacques-Olivier ;

Wei, Andrew ;

Groepper, Stefanie ;

Papayannidis, Cristina ;

Owen, Kate ;

Pike, Laura ;

Schmitt, Nicola ;

Stockman, Paul K. ;

Giagounidis, Aristoteles .

CANCER, 2013, 119 (14) :2611-2619

[6] Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia [J].

Lowenberg, Bob ;

Muus, Petra ;

Ossenkoppele, Gert ;

Rousselot, Philippe ;

Cahn, Jean-Yves ;

Ifrah, Norbert ;

Martinelli, Giovanni ;

Amadori, Sergio ;

Berman, Ellin ;

Sonneveld, Pieter ;

Jongen-Lavrencic, Mojca ;

Rigaudeau, Sophie ;

Stockman, Paul ;

Goudie, Alison ;

Faderl, Stefan ;

Jabbour, Elias ;

Kantarjian, Hagop .

BLOOD, 2011, 118 (23) :6030-6036

[7] Modeling the temporal evolution of the spindle assembly checkpoint and role of Aurora B kinase [J].

Mistry, Hitesh B. ;

MacCallum, David E. ;

Jackson, Robert C. ;

Chaplain, Mark A. J. ;

Davidson, Fordyce A. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (51) :20215-20220

[8] Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinase [J].

Mortlock, Andrew A. ;

Foote, Kevin M. ;

Heron, Nicola M. ;

Jung, Frederic H. ;

Pasquet, Georges ;

Lohmann, Jean-Jacques M. ;

Warin, Nicolas ;

Renaud, Fabrice ;

De Savi, Chris ;

Roberts, Nicola J. ;

Johnson, Trevor ;

Dousson, Cyril B. ;

Hill, George B. ;

Perkins, David ;

Hatter, Glenn ;

Wilkinson, Robert W. ;

Wedge, Stephen R. ;

Heaton, Simon P. ;

Odedra, Rajesh ;

Keen, Nicholas J. ;

Crafter, Claire ;

Brown, Elaine ;

Thompson, Katherine ;

Brightwell, Stephen ;

Khatri, Liz ;

Brady, Madeleine C. ;

Kearney, Sarah ;

McKillop, David ;

Rhead, Steve ;

Parry, Tony ;

Green, Stephen .

JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (09) :2213-2224

[9] A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia [J].

Tsuboi, Kosuke ;

Yokozawa, Toshiya ;

Sakura, Toru ;

Watanabe, Takashi ;

Fujisawa, Shin ;

Yamauchi, Takahiro ;

Uike, Naokuni ;

Ando, Kiyoshi ;

Kihara, Rika ;

Tobinai, Kensei ;

Asou, Hiroya ;

Hotta, Tomomitsu ;

Miyawaki, Shuichi .

LEUKEMIA RESEARCH, 2011, 35 (10) :1384-1389

← 1 →